Acer Therapeutics Inc
ACER
ACER was delisted on the 8th of November, 2023.
16 hedge funds and large institutions have $7.7M invested in Acer Therapeutics Inc in 2017 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 0 closing their positions.
96,100% more capital invested
Capital invested by funds: $8K → $7.7M (+$7.69M)
300% more funds holding
Funds holding: 4 → 16 (+12)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
+$2.44M |
| 2 |
JGC
J. Goldman & Co
New York
|
+$1.76M |
| 3 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$1.63M |
| 4 |
PVI
Pura Vida Investments
New York
|
+$1.48M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
+$1.22M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$554 |
ACER Hedge Fund Activity: Q4 2017 in Review
16 of the 4,419 institutional investors tracked by Wall St. Rank reported a position in Acer Therapeutics Inc (ACER) for Q4 2017, worth a combined $7.7M — up 96,100% from $8K a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new ACER positions and 0 closed out — a net gain of 12 holders — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Perceptive Advisors, opening a new position worth an estimated $2.44M. The largest seller was Morgan Stanley, cutting an estimated $554.
- 16 institutional investors held Acer Therapeutics Inc (ACER) as of Q4 2017, up from 4 in Q3 2017.
- Funds reported $7.7M of Acer Therapeutics Inc stock for Q4 2017, up 96,100% quarter-over-quarter.
- 12 funds opened new Acer Therapeutics Inc positions in Q4 2017 and 0 closed out, a net change of +12 holders.
- The largest Acer Therapeutics Inc buyer in Q4 2017 was Perceptive Advisors, an estimated $2.44M added.
- The largest Acer Therapeutics Inc seller in Q4 2017 was Morgan Stanley, an estimated $554 sold.
Based on aggregated 13F filings for Q4 2017.